Intelligence Β· Patent portfolio
Takeda Patents
Full USPTO pharma patent portfolio for Takeda β grant dates, expiration, and drug cross-links.
- Patents
- 1,436
- Expiring β€24m
- 81
Quick answer
Takeda has 1,436 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 81 expire within 24 months β use filters for patent-cliff planning.
-
US 7132547
Preventives/remedies for urinary disturbance
granted -
US 7109200
Carbamate derivatives, process for producing the same and use thereof
granted -
US 7105572
Stable emulsion compositions
granted -
US 7101867
Benzofuran derivatives, their production and use
granted -
US 7101899
5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
granted -
US 7090869
Method for producing preparation containing bioactive substance
granted -
US 7091247
Biphenyl compound
granted -
US 7087597
Pyrimidine 5-carboxamide compounds, process for producing the same and use thereof
granted -
US 7084149
Naphthalene derivatives, their production and use
granted -
US 7078540
Substituted aromatic-ring compounds, process for producing the same, and use
granted -
US 7074761
Peptides and production and use thereof
granted -
US 7070975
Protein and DNA thereof
granted -
US 7070805
Rapidly disintegrable solid preparation
granted -
US 7067537
Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
granted -
US 7067527
Thienopyridine derivatives, their production and use
granted -
US 7067546
Crystal and process for producing the same
granted -
US 7064141
Method for preventing, treating or inhibiting development of simple retinopathy and preproliferative retinopathy
granted -
US 7064106
Gene and use thereof
granted -
US 7064181
Physiologically active peptide and its use
granted -
US 7053053
Humanin-like peptide and use thereof
granted -
US 7049403
Insulin/IGF/relaxin family polypeptides and DNAS thereof
expired -
US 7048947
Sustained-release preparation
expired -
US 7045299
Physiologically active peptide and use thereof
expired -
US 7045497
Use of peptide
expired -
US 7041789
RFRP-3 and DNA thereof
expired -
US 7033771
Use of insulin response modulators in the treatment of diabetes and insulin resistance
expired -
US 7034039
Fused heterocyclic compounds
expired -
US 7022725
Isoxazole derivatives
expired -
US 7019106
Lactic acid polymer and process for producing the same
expired -
US 7008940
Dihydrobenzofuran derivatives, process for the preparing thereof and agents
expired -
US 7008950
Benzofurans as suppressors of neurodegeneration
expired -
US 7001997
Proteins, their production and use
expired -
US 6991908
Antiobestic agents methods for screening antiobestic agents and kits comprising same
expired -
US 6992171
Polypeptide and its DNA
expired -
US 6984653
Heterocyclic compounds, oxazole derivatives, process for preparation of the same and use thereof
expired -
US 6982348
Aminoethanol derivatives
expired -
US 6982275
Process for producing optically active sulfoxide derivative
expired -
US 6974806
Lipid-rich plaque inhibitors
expired -
US 6962919
Nitrogen-containing heterocyclic compounds, their production and use
expired -
US 6962933
Method for inhibiting p38 MAP kinase or TNF-Ξ± production using a 1,3-thiazole
expired -
US 6960586
Imidazole derivatives, process for their preparation and their use
expired -
US 6953789
Thiol compounds, their production and use
expired -
US 6951885
Pharmaceutical composition
expired -
US 6949648
Condensed pyrazole derivatives, process for producing the same and use thereof
expired -
US 6939971
Benzimidazole compound crystal
expired -
US 6936602
Benzazepine derivatives, process for the preparation of the same and uses thereof
expired -
US 6930185
Melanin-concentrating hormone antagonist
expired -
US 6930104
Heterocyclic derivatives
expired
Frequently asked questions
How many patents does Takeda have?
1,436 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Takeda patents expire?
81 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory